El Oakley Reida, Shah Aijaz
Department of Cardiac Surgery, Benghazi Medical Center, Benghazi, Libya.
ISRN Cardiol. 2011;2011:858714. doi: 10.5402/2011/858714. Epub 2011 Jul 14.
Mitral regurgitation (MR) has previously been classified into rheumatic, primary, and secondary MR according to the underlying disease process. Carpentier's/Duran functional classifications are apt in describing the mechanism(s) of MR. Modern management of MR, however, depends primarily on the severity of MR, status of the left ventricular function, and the presence or absence of symptoms, hence the need for a management-oriented classification of MR. In this paper we describe a classification of MR into 4 phases according to LV function: phase I = MR with normal left ventricle, phase II = MR with normal ejection fraction (EF) and indirect signs of LV dysfunction such as pulmonary hypertension and/or recent onset atrial fibrillation, phase III = EF ≥ 30%-< 50% and/or mild to moderate LV dilatation (ESID 40-54 mm), and phase IV = EF < 30% and/or severe LV dilatation (ESDID ≥ 55 mm). Each phase is further subdivided into three stages: stage "A" with an effective regurgitant orifice (ERO) < 20 mm, stage "B" with an ERO = 20-39 mm, and stage "C" with an ERO ≥ 40 mm. Evidence-based indications and outcome of intervention for MR will also be discussed.
二尖瓣反流(MR)先前已根据潜在疾病进程分为风湿性、原发性和继发性MR。Carpentier/Duran功能分类法适用于描述MR的机制。然而,MR的现代治疗主要取决于MR的严重程度、左心室功能状态以及症状的有无,因此需要一种以治疗为导向的MR分类法。在本文中,我们根据左心室功能将MR分为4个阶段:I期=左心室正常的MR,II期=射血分数(EF)正常但有左心室功能障碍间接征象(如肺动脉高压和/或近期发作的心房颤动)的MR,III期=EF≥30%<50%和/或轻度至中度左心室扩张(舒张末期内径40 - 54mm),IV期=EF<30%和/或严重左心室扩张(舒张末期内径≥55mm)。每个阶段进一步细分为三个阶段:“A”阶段有效反流口(ERO)<20mm,“B”阶段ERO = 20 - 39mm,“C”阶段ERO≥40mm。还将讨论MR基于证据的干预指征和干预结果。